Galen Data Inc., a leading cloud platform for medical devices, today announced its newest partnership with Advanced TeleSensors Inc. (ATS), maker of the Cardi/o® touchless monitor. This partnership powers a much-needed technology during the COVID-19 crisis.
The Galen Cloud® turnkey solution gives ATS a secure and FDA-compliant cloud environment along with analytics for data captured by the Cardi/o® monitoring device used to perform remote, touchless vital-sign monitoring of at-risk patients. The Galen Cloud® provides data access and alerts to ATS, individual users, and their care team.
“We wish we had found Galen Data sooner. We had been building our own cloud for six months, thinking a custom solution would best meet our needs'' said Sajol Ghoshal, CEO and President of ATS. “Getting up-and-running with them was very easy, and it allowed us to focus on our core competency — which is data-signal processing.”
Cardi/o® uses radio frequency processing to provide remote, touchless monitoring of individuals’ vital signs. The company’s founders, Caltech scientists, developed the core technology behind the product at NASA’s Jet Propulsion Lab. The initial use case for these monitoring devices is in assisted living facilities as well as for at-risk patients in the home setting. Such technologies are especially important now, as seniors are increasingly isolated due to COVID-19 and can benefit from a technology to provide that safety and peace of mind.
The founders of Galen Data have a combined 50+ years of experience in healthcare technology, medical devices, and regulatory compliance. They met while working together for a software contractor building safety systems for NASA. Recognizing that the Internet of Things (IoT) would change the landscape for connected medical devices, its leadership built the first turnkey cloud solution for medical device makers. The company’s platform offers a configurable, secure, and compliant cloud, reducing time, cost, and risk for the medical device maker.
“We knew that our platform would be a great fit for Cardi/o,” Chris DuPont, CEO of Galen Data said. “Speed was critical, accentuated by the COVID-19 crisis. We were well positioned to address ATS’ needs, and help those at-risk in the process.”